x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Oncology Brothers: Practice-Changing Cancer Discussions

Oncology Brothers

On a mission to disseminate information to the community and bridge the gap between academia and community oncology in this rapidly changing field of hematology & oncology. Drs. Rahul & Rohit Gosain interview world-renowned hematologists/oncologists to present the practice-changing data in a small bite-sized format where one could immediately apply that information in their daily practice to provide the best cancer care to their patients close to home. Privacy Policy:

health & fitness medicine

All Episodes

00:22:11

Liver Directed Therapies - Interventional Radiology &...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/05/09

In this episode of the Oncology Brothers podcast, join Drs. Rahul and Rohit Gosain as they delve into the world of localized treatment options for gastrointestinal malignancies. They are joined by experts in the field, Drs. Nina Sanford, Jeffrey Ryckman, and Harris Chengazi, who provide insights into radiation oncology and interventional radiology modalities for treating liver cancer. The discussion covers the basics of radiation oncology terminology, including SRS, SBRT, and proton therapy, and

en

00:22:27

Discussing Treatment Algorithm for Newly Diagnosed...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/05/06

Welcome back to another informative episode of the Oncology Brothers podcast! In this episode, hosts Rahul and Rohit Gosain are joined by Dr. Caitlin Costello, an associate professor specializing in multiple myeloma at UC San Diego. Together, they delve into the evolving landscape of newly diagnosed multiple myeloma, covering essential topics such as diagnostic workup, treatment paradigms, and the role of minimal residual disease (MRD) in monitoring response. Dr. Costello provides valuable insights

en

00:25:15

Discussion on Evolving CLL Treatment Strategies with...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/04/29

In this informative podcast episode, the Oncology Brothers delve into the world of hematologic malignancies, focusing specifically on Chronic Lymphocytic Leukemia (CLL). Dr. Nitin Jain from MD Anderson Cancer Center joins the discussion, sharing insights on the latest treatment options and guidelines for CLL. The episode covers essential topics such as determining when a patient with CLL needs treatment, the minimal workup required for scans and biopsies, and the decision-making process between

en

00:14:59

FRESCO2 Study: FDA Approval of Fruquintinib for...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/04/25

Join us for yet another episode of The Oncology Brothers podcast, where we delve into the FRESCO2 study in metastatic colorectal cancer. In this episode, we are joined by Dr. Arvind Dasari from MD Anderson, the lead author of the study, to discuss the approval of fruquintinib and its impact on refractory colorectal cancer patients. Discover how fruquintinib has significantly improved progression-free and overall survival, providing a new treatment option for patients who have exhausted other

en

00:26:02

Standard of Care Treatment for Upper GI Cancer: A...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/04/22

Welcome to another insightful episode of the Oncology Brothers podcast! In this episode, hosts Rahul and Rohit Gosain are joined by Dr. Sam Klempner, a medical oncologist specializing in upper GI malignancies. Together, they delve into the current treatment strategies for esophageal, GE junction, and gastric adenocarcinoma. The discussion covers a range of topics, including the evolving paradigms in neoadjuvant and adjuvant therapies, the importance of biomarker testing such as MSI and PD-L1, and

en

00:21:46

Standard of Care Treatment for Colon Cancer: A...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/04/10

In this episode of Oncology Brothers, join hosts Drs. Rahul and Rohit as they dive into the management of colon cancer with special guest Dr. Aparna Parikh, a medical oncologist from Mass General Hospital. Dr. Parikh shares insights on the treatment algorithm for colon cancer, including the use of circulating tumor DNA and the latest advancements in treatment options. From localized disease to metastatic space, the discussion covers key aspects of managing colon cancer. Tune in to learn about the

en

00:25:10

Unpacking the Treatment Algorithm of Hepatocellular...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/04/01

Join the Oncology Brothers, Drs. Rahul and Rohit Gosain, in this engaging podcast episode as they delve into the treatment landscape for hepatocellular carcinoma (HCC) with Dr. Tanios S. Bekaii-saab from Mayo Clinic. The discussion covers the treatment options for different stages of HCC, including liver transplant, local therapy, and systemic treatments. Dr. Tanios S. Bekaii-saab provides insights on utilizing Atezolizumab with Bevacizumab, dual checkpoint inhibitors, and TKIs in advanced or

en

00:18:35

Breakthrough in Bladder Cancer: FDA approval -...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/03/27

Join the Oncology Brothers, Drs. Rahul and Rohit Gosain, as they dive deep into the groundbreaking EV302 study with special guest Dr. Thomas Powles. In this episode, they discuss the approval of Enfortumab and Pembrolizumab as a combination therapy for advanced bladder cancer, based on the remarkable results of the study. Dr. Powles shares insights on the study design, findings, and the transformative impact of the treatment on patients' lives. Discover how this new standard of care in bladder

en

00:23:55

Bladder Cancer Treatment Algorithm Discussion with...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/03/22

Bladder Cancer Treatment Options: A Comprehensive Discussion | Oncology Brothers Podcast Join the Oncology Brothers, Rahul Gosain and Rohit Gosain, in this insightful podcast episode where they are joined by Dr. Karine Tawagi, a medical oncologist, and Dr. Sia Daneshmand, a urologist, to discuss the current standard of care and treatment options for bladder cancer. In this episode, the experts delve into the treatment approaches for non-muscle invasive bladder cancer, including the use of BCG,

en

00:18:49

Exploring the Latest in Renal Cell Cancer Therapies...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/03/11

In this episode joined by Dr. Monty Pal from City of Hope to discuss the latest advancements in the treatment of renal cell cancer. The conversation covers topics such as adjuvant pembrolizumab, personalized medicine, second-line treatment options, and the role of TKIs and immune checkpoint inhibitors. Dr. Pal shares insights on clinical pearls, treatment algorithms, and ongoing clinical trials in the field. Tune in to stay informed about the current standard of care practices in renal cell cancer

en

00:23:10

How to treat Prostate Cancer in 2024 with Dr. Rana McKay

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/02/26

In discussion with Dr. Rana McKay, Associate Professor of Medicine from UC San Diego Health, we covered the treatment algorithm for Prostate cancer, starting from localized disease and then focusing on CSPC and CRPC. #Prostate #Cancer #Cancer #2024 #oncology #oncbrothers Website: http://www.oncbrothers.com/ Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

en

00:21:41

Dr. Hope Rugo discusses Capivasertib FDA Approval...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/02/22

In this discussion with Dr. Hope Rugo, we covered her study Capitello-291, which led to the approval of Capivasertib in hormone receptor-positive breast cancer with AKT1, PTEN, and PIK3CA mutations, which are seen in 40-50% of the cases. We touched base on sequencing of this therapy, and important clinical pearls around the side effect management associated with this drug.

en

00:21:02

How to Treat HR+ Breast Cancer with Dr. Virginia...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/02/15

In discussion with Dr. Virginia Kaklamani, we cover treatment algorithm of HR+ breast cancer. We covered the current standard of care treatment options for HR+ breast cancer. #HER2 #Sensitive #Breast #Cancer #2024 #oncology #oncbrothers Website: http://www.oncbrothers.com/ Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

en

00:17:45

GU ASCO 2024 Highlights with Dr. Tian Zhang –...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/02/08

In discussion with Dr. Tian Zhang, covering the Genitourinary ASCO 2024 meeting highlights from the Community Oncology perspective. We covered 4 important practice informing studies from GU ASCO with Dr. Zhang: - CONTACT-02: Phase 3 study of cabozantinib plus atezolizumab vs second novel hormonal therapy in patients with metastatic castration-resistant prostate cancer - BRCAAway: A randomized phase 2 trial of abiraterone, olaparib, or abiraterone + olaparib in patients with metastatic

en

00:22:11

How to treat HER2+ Breast Cancer in 2024 with Dr....

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/02/05

In discussion with Dr. Harold Burstein, we cover treatment algorithm of HER2+ breast cancer. We covered the current standard of care treatment options for HER2+ breast cancer. #HER2 #Sensitive #Breast #Cancer #2024 #oncology #oncbrothers Website: http://www.oncbrothers.com/ Twitter: https://twitter.com/oncbrothers Contact us at info@oncbrothers.com

en

00:21:06

GI ASCO 2024 Highlights with Dr. Pamela Kunz –...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/02/01

In discussion with Dr. Pamela Kunz, covering the Gastroenterology ASCO 2024 meeting highlights from Community Oncology perspective. We covered 3 important practice informing studies from GI ASCO with Dr. Kunz: - CheckMate 8HW: Nivolumab plus ipilimumab vs chemotherapy as first-line (1L) treatment for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer - EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization

en

00:18:37

How to Treat Triple Negative Breast Cancer | Dr. Ruth...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/01/24

Discussing the management using the algorithm of Triple Negative Breast Cancer (TNBC) - with Dr. Ruth O'Regan Chair of medicine Charles A. Dewey Professor at the University of Rochester Wilmot Cancer Institute & Dr. Anna Weiss Associate Professor - Department of Surgery, Oncology Wilmot Cancer Institute.

en

00:16:27

ASH 2023 Leukemia/MDS/Myelofibrosis Highlights –...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/01/17

In discussion with Dr. Uma Borate from the Ohio State University Comprehensive Cancer Center, The James, covering the leukemia, myelofibrosis and myelodysplastic syndrome key practice changing/informing abstracts from American Society of Hematology (ASH) 2023 conference from Community Oncology perspective. We covered 4 important practice informing studies with Dr. Borate: - TRANSFORM-1: Ph III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, International, Study of Navitoclax in

en

00:14:34

SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/01/11

In discussion with Dr. Daniel G. Stover, covering the San Antonio Breast Cancer Symposium 2023 Highlights from Community Oncology perspective. We covered 3 important practice informing studies in HER2+ disease with Dr. Stover: - APHINITY Sub-analysis: Benefit of Adj Pertuzumab and Trastuzumab According to ER and HER2 Expression - KATHERINE Update: Phase III Study of Adjuvant TDM-1 vs Trastuzumab for Residual Invasive HER2-positive Early Breast Cancer After Neoadj Chemo: Final IDFS and Updated OS

en

00:22:41

SABCS 2023 Breast Cancer Highlights – NATALEE,...

Oncology Brothers: Practice-Changing Cancer Discussions ·

2024/01/09

In discussion with Dr. Hope Rugo, covering the San Antonio Breast Cancer Symposium 2023 Highlights from Community Oncology perspective. We covered 4 important practice informing studies with Dr. Rugo: - NATALEE Update – Ribociclib + Nonsteroidal AI as Adj Treatment in Patients with HR+/HER2− Early Breast Cancer: Final iDFS analysis - MONARCH 3 – Final OS Results of Abemaciclib Plus a Nonsteroidal AI as First-line Therapy for HR+, HER2– Advanced Breast Cancer - INAVO120 – Phase III Study of

en

195 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown